iShares Biotechnology ETF (NASDAQ:IBB) Declares Dividend Increase – $0.12 Per Share

iShares Biotechnology ETF (NASDAQ:IBB) declared a dividend on Monday, March 17th, NASDAQ Dividends reports. Stockholders of record on Tuesday, March 18th will be paid a dividend of 0.1212 per share by the financial services provider on Friday, March 21st. The ex-dividend date is Tuesday, March 18th. This is a 94.3% increase from iShares Biotechnology ETF’s previous dividend of $0.06.

iShares Biotechnology ETF Trading Down 1.5 %

IBB traded down $2.01 on Tuesday, hitting $134.09. The company had a trading volume of 509,360 shares, compared to its average volume of 1,325,954. The company’s fifty day moving average price is $136.28 and its 200 day moving average price is $139.67. iShares Biotechnology ETF has a 1 year low of $123.60 and a 1 year high of $150.57. The firm has a market cap of $6.11 billion, a P/E ratio of 27.83 and a beta of 0.77.

Hedge Funds Weigh In On iShares Biotechnology ETF

An institutional investor recently bought a new position in iShares Biotechnology ETF stock. Brighton Jones LLC bought a new stake in iShares Biotechnology ETF (NASDAQ:IBB) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 1,517 shares of the financial services provider’s stock, valued at approximately $201,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.